Response Genetics to Partner with UCSF on Pancreatic Cancer Dx Development | GenomeWeb
NEW YORK (GenomeWeb News) - Response Genetics today said it will work with the University of California, San Francisco, on a two-year research study aimed at developing a diagnostic test kit for pancreatic cancer.
 
The company said the study will combine data from patient outcomes with genetic information from formalin-fixed paraffin-embedded samples of pancreatic tissue provided by UCSF.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.